Track the 동성제약 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 동성제약 has logged 41 public disclosures. Market capitalisation: €171.5bn. The latest transaction was disclosed on 6 April 2026 (Purchase). Among the most active insiders: 이양구. All data is openly available.
41
Insider Decl.
n/a
Thresholds
€40m
29 ops.
Buy Volume
n/a
2 ops.
Sell Volume
19Σ signal
Buys €40mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,395 of 28,065 companies
24.9
score / 100
Value
16
Quality
34
FCF yld-8.3%
Earn yld-15%
EV/EBITDA·
ROE2.9%
Gross mgn43%
Net mgn-30%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
동성제약 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the research, development, and manufacturing of pharmaceutical products.